News

Breast cancer is the most common cancer in women and like every cancer, there is a chance of breast cancer recurrence even after completion of the prescribed treatment. Hence, every woman has to ...
The Business Research Company's Lung Cancer Liquid Biopsy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% On All Global Market Reports With Code ONLINE30 – Stay ...
Circulating tumor cells (CTC) have been represented by different phenotypes due to the epithelial–mesenchymal transition (EMT), which are epithelial CTC (E-CTC), mesenchymal CTC (M-CTC), and mixed ...
Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with ...
This method has been utilized to capture CTCs from the blood of patients with metastatic non-small-cell lung cancer, to perform EGFR mutational analysis on DNA recovered from these cells in order ...
Government data projects nearly 620,000 cancer deaths in the U.S. this year. However, a new "Trojan horse" therapy could ...
Same mutations detected by the multicancer early detection test at index time point could be ID'd at 8.6- to 79-fold lower mutant allele fractions. (HealthDay News) — Circulating tumor DNA can ...
NHS England is set to introduce a pioneering liquid biopsy blood test, offering new hope to lung and breast cancer patients. The innovative test, a world-first, will analyse tumour DNA fragments ...
With support from a three-year, $1.85 million grant from the U.S. Department of Defense (“Role of TBX2 in the establishment of the Prostate Cancer Pre-Metastatic Niche (PMN) in the Bone ...
AbstractPurpose:. Ipilimumab (IPI) improved outcomes for patients with high-risk melanoma compared with IFN-α2b in E1609, a phase III adjuvant trial. We hypothesized that combining candidate immune ...
AbstractActivating mutations in KRAS drive tumorigenesis in pancreatic ductal adenocarcinoma (PDAC), promoting tumor cell proliferation and contributing to an immunosuppressive tumor microenvironment, ...